Cargando…

The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy

OBJECTIVE: Patients who undergo radical hysterectomy may require postoperative adjuvant radiotherapy, and all efforts should be made to reduce dual therapy in such patients. The aim of this study was to determine the optimal upper limit of tumor size in patients with International Federation of Gyne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Woo Yeon, Kim, Ju-Hyun, Suh, Dong Hoon, Kim, Kidong, No, Jae Hong, Kim, Yong Beom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398224/ https://www.ncbi.nlm.nih.gov/pubmed/32467336 http://dx.doi.org/10.1136/ijgc-2020-001271

Ejemplares similares

Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer
por: Ding, Yan, et al.
Publicado: (2022)

Identifying selection criteria for non‐radical hysterectomy in FIGO stage IB cervical cancer
por: Kasamatsu, Takahiro, et al.
Publicado: (2019)

Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting
por: Jung, Phill-Seung, et al.
Publicado: (2015)

Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2019)

Matched-Case Comparisons in a Single Institution to Determine Critical Points for Inexperienced Surgeons’ Successful Performances of Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Stage IA2-IIA Cervical Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2015)

Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
por: Cetina, Lucely, et al.
Publicado: (2007)

Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix
por: Kasamatsu, T, et al.
Publicado: (2009)

Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2014)

Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2
por: Choi, Yae Ji, et al.
Publicado: (2021)

Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study)
por: Nakamura, Kazuto, et al.
Publicado: (2016)

Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2016)

Risk Factor and Treatment of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Intraepithelial Neoplasia
por: Kim, Ju-Hyun, et al.
Publicado: (2022)

The incidence of urologic complications requiring urologic procedure in radical hysterectomy and difference between abdominal radical hysterectomy and laparoscopic radical hysterectomy
por: Kim, Hyeongsu, et al.
Publicado: (2021)

Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer
por: Kim, Se Ik, et al.
Publicado: (2021)

Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage
por: Balaya, Vincent, et al.
Publicado: (2020)

Robot-assisted versus conventional laparoscopic radical hysterectomy in cervical cancer stage IB1
por: Kim, Sang Il, et al.
Publicado: (2023)

Laparotomic radical hysterectomy versus minimally invasive radical hysterectomy using vaginal colpotomy for the management of stage IB1 to IIA2 cervical cancer: Survival outcomes
por: Yang, Eun Jung, et al.
Publicado: (2022)

Survival Outcomes of Patients With Stage IB3 Cervical Cancer Who Undergo Abdominal Radical Hysterectomy Versus Radiochemotherapy
por: Li, Zhiqiang, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
por: Chen, Xiaolin, et al.
Publicado: (2022)

Effect of the Number of Removed Lymph Nodes on Survival in Patients with FIGO Stage IB-IIA Cervical Squamous Cell Carcinoma following Open Radical Hysterectomy with Pelvic Lymphadenectomy: A Retrospective Cohort Study
por: Guo, Qinhao, et al.
Publicado: (2021)

Comparison of the Oncological Outcomes Between Robot-Assisted and Abdominal Radical Hysterectomy for Cervical Cancer Based on the New FIGO 2018 Staging System: A Multicentre Retrospective Study
por: Li, Pengfei, et al.
Publicado: (2022)

Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era
por: Kim, Jin Hee, et al.
Publicado: (2019)

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery
por: Zhang, Xiaojing, et al.
Publicado: (2020)

Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
por: Park, Jeong-Yeol, et al.
Publicado: (2012)

The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas
por: Brambs, Christine E., et al.
Publicado: (2019)

Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Association of nursing-documented ambulation with length of stay following total laparoscopic hysterectomy for benign gynecologic disease
por: Kim, Kidong, et al.
Publicado: (2013)

Neoadjuvant Chemotherapy Prior Fertility-Sparing Surgery in Women with FIGO 2018 Stage IB2 Cervical Cancer: A Systematic Review
por: Buda, Alessandro, et al.
Publicado: (2022)

Reviewing FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2023)

Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis
por: Zhao, Wancheng, et al.
Publicado: (2021)

Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2022)

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

Prognostic Significance of DNA Cytometry in Carcinoma of the Uterine Cervix FIGO Stage IB and II
por: Grote, Hans Jürgen, et al.
Publicado: (2001)

Feasibility of radical hysterectomy in women with FIGO stage IIB cervical cancer: an observation study of 10-year experience in a tertiary center
por: Yuan, Lei, et al.
Publicado: (2018)

Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
por: Zang, Lele, et al.
Publicado: (2021)

Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection
por: Yoo, Baraem, et al.
Publicado: (2017)

Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy
por: Chen, Zhilan, et al.
Publicado: (2016)

자궁경부암: 개정된 2018 FIGO 병기와 자기공명영상을 중심으로
Publicado: (2021)

Critical analysis of the FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qtvu3gen0rlvuh5gfpbjshurap